REGENERATION OF MYOCARDIAL PHOSPHOCREATINE IN PIGS DESPITE CONTINUED MODERATE ISCHEMIA
REGENERATION OF MYOCARDIAL PHOSPHOCREATINE IN PIGS DESPITE CONTINUED MODERATE ISCHEMIA
复制标题
DOI:
10.1161/01.res.67.6.1481
复制
发表时间:
1990-12-01
影响因子:
20.1
通讯作者:
BRISTOW, JD
中科院分区:
文献类型:
--
作者:
PANTELY, GA;MALONE, SA;BRISTOW, JD
The effects of 1 hour of milk and moderate reductions in coronary blood flow in myocardial high-energy phosphate levels were evaluated. Thirty anesthetized pigs were instrumented with left anterior descending arterial and venous catheters, crystals for instantaneous wall thickness, and a fluid-filled occluder. Measurement of myocardial blood flow was performed with microspheres, and a series of myocardial biopsies also was performed. In 10 pigs, overall coronary blood flow was lowered by 22%, with a fall in subendocardial-to-subepicardial flow ratio from 1.11 to 0.54 an in wall thickening from 33% to 15%. Subendocardial flow fell 48%. Coronary blood flow and thickening were constant during 1 hour of ischemia. Phosphocreatine (.mu.mol/g wet wt) in the subendocardical third of the ischemic zone fell from 7.6 to 3.8 at 5 minutes of ischemia (p < 0.005 verus control) and returned to normal (7.9) at 60 minutes (p = NS), despite ongoing ishemia. Subendocardial ATP (.mu.mol/g wet wt) fell slowly from 4.3 and leveled off at 2.1 at 60 minutes of ischemia (p < 0.001 versus control). Similar regeneration of phosphocreatine was found in seven additional pigs, with a 43% transmural reduction in coronary blood flow and a 66% reduction in subendocardial flow. No significant changes in ATP and phosphocreatine were noted in two different control groups (n = 13 pigs). The regeneration of phosphocreatine despite ongoing ischemia and low ATP levels was not related to changes in myocardial oxygen demand or consumption, or in regional function during the period of ischemia. This may reflect 1) a successful downregulation of the energy needs of the ischemic myocardium to maintain cell viability, or 2) a metabolic abnormality in the ability of the cells to produce ATP primarily or by use of phosphocreatine.